GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway

Gemcitabine-based chemotherapy is the first-line treatment for pancreatic cancer. However, chemoresistance is a major obstacle to drug efficacy, leading to poor prognosis. Little progress has been achieved although multiple mechanisms are investigated. Therefore, effective strategies are urgently ne...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Oncol
Main Authors: Chang, Zhenyu, Zhang, Yanan, Liu, Jie, Guan, Chengjian, Gu, Xinjin, Yang, Zelong, Ye, Qinong, Ding, Lihua, Liu, Rong
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481023/
https://ncbi.nlm.nih.gov/pubmed/31093285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9474273
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados